ClinicalTrials.gg
CompletedNCT05738837SARE-AUpdated Apr 14, 2026

An Evaluation of a Sexual Assault Resistance Program for Adolescent Girls

An interventional study of A-EAAA Sexual Assault Resistance Education Program immediately and Usual care + A-EAAA at 6 months in Sexual Assault, sponsored by University of Windsor. Completed at 1 site in Canada. Open to participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by University of Windsor · Not applicable, Interventional, and Prevention

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
343
Allocation
Randomized
Ages
14 Years to 18 Years
Sex
All
01

Study summary

Sexual violence (SV) perpetrated by dating partners and male acquaintances is common among adolescent girls in high school. Girls and young women who experience SV are likely to encounter negative mental and physical health consequences as well as lowered academic performance. While educational interventions to address the problem of SV are numerous, when evaluated, few show any capacity to reduce sexual violence victimization or perpetration. The Enhanced Assess, Acknowledge, Act (EAAA) sexual assault resistance program for female university students (ages 17-24) is a rare exception; in a rigorous trial, EAAA reduced attempted and completed rape by 50% in the following year. The current randomized controlled trial (RCT) will test whether a version of EAAA that has been adapted for younger girls (age 14-18) who have not graduated high school (called the Adolescent Enhanced Assess, Acknowledge, Act [A-EAAA]) will result in similar benefits within a 6-month follow-up. The current RCT will be conducted across three sites in Ontario, Canada.

Read the detailed description

Sexual violence (SV), which occurs along a continuum from unwanted sexual contact to rape, is common among adolescent girls and young women: research suggests 1 in 7 teen girls experiences SV. Perpetrators of SV are overwhelmingly male; however, the programs that exist to address boys'/men's perpetration are not sufficiently effective nor are they widely available. Other approaches to sexual assault prevention for adolescents, such as bystander programs, have not been shown to reduce sexual violence victimization or perpetration. Given the numerous negative consequences associated with SV, developing effective SV prevention and resistance programs targeting teens is critical for reducing victimization and improving health outcomes for adolescent girls. The Enhanced Assess, Acknowledge, Act (EAAA) sexual assault resistance program has been shown to substantially reduce rates of SV (50% for rape and attempted rape) in young women attending university (ages 17-24), but since it was designed for university students in a different developmental stage, an evidence-based adaptation was necessary. The purpose of the current study is to test the efficacy of the newly adapted Adolescent Enhanced Assess, Acknowledge, Act (A-EAAA) program in reducing sexual violence victimization among adolescent girls within 6-months of trial entry. We will continue to follow participants for one-year to evaluate whether changes in tertiary outcomes (e.g., mediators) are maintained to 12-months. A-EAAA is a 12-hour psychoeducational intervention that provides information, skills, and practice aimed at a) decreasing the time needed for girls to assess sexually coercive situations as dangerous and to take action, b) reducing emotional obstacles to taking action, c) increasing the use of the most effective methods of verbal and physical self-defense, and d) identifying sexual and relationship values and boundaries and reinforcing the right to defend them.

02

Conditions studied

  • Sexual Assault

Keywords

  • intervention
  • adolescents
  • sexual assault
  • rape
  • dating violence
  • gender-based violence
  • girls' health
  • prevention
03

In context

Lead sponsor

University of Windsor is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-identified girls aged 14 to 18 years;
  • have not graduated high school;
  • competence in spoken and written English;
  • provide ;
  • able to attend one of the scheduled programs in the data collection period in which they are enrolled.

Exclusion criteria

Exclusion Criteria:

None

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
343 participants (actual)

Study arms

  • Experimental
    A-EAAA (Adolescent Enhanced Assess, Acknowledge, Act) immediately

    Adolescent adaptation of EAAA sexual assault resistance education (4, 3-hr sessions) begun immediately after baseline randomization

    Behavioral: A-EAAA Sexual Assault Resistance Education Program immediately

  • Active comparator
    Waitlist Control

    Usual care 30-min session (brief presentation on consent/sexual assault; access to local resource pamphlets) immediately after baseline randomization; A-EAAA (4, 3-hr sessions) at 6-months post-randomization

    Behavioral: Usual care + A-EAAA at 6 months

Interventions

  • BehavioralA-EAAA Sexual Assault Resistance Education Program immediately

    Adapted from the EAAA program created for university women, A-EAAA is designed for teen girls of all sexual identities and experience levels. It focuses on resisting sexual assault (SA) committed by male acquaintances with 4, 3-hour units: Unit 1(Assess) strengthens girls' ability to detect risk in contexts involving male acquaintances and helps develop strategies to reduce it. Unit 2(Acknowledge) helps girls explore ways to overcome their own emotional barriers preventing them from acknowledging risk and employing effective resistance strategies with males they know. Unit 3(Act) provides evidence on effectiveness of various resistance strategies and teaches verbal and physical self-defense focused on common acquaintance SA situations. Unit 4 (Relationships\&Sexuality) is an adaptation of Our Whole Lives curriculum and aims to increase girls' comfort talking about sex/sexuality and identify their sexual values/desires and explore possibilities for sexual practices beyond intercourse.

    Also known as: Girls -- Flip the Script with EAAA

  • BehavioralUsual care + A-EAAA at 6 months

    Participants assigned to the waitlist control group will immediately receive a brief educational session on sexual assault that represents the current 'standard of care' at Canadian high schools (often presented by local Sexual Assault Centres or Public Health nurses). This 30-min session will involve a brief 15 - 20-minute presentation on sexual consent, respect in relationships, and sexual assault (e.g., definitions, prevalence statistics). This will be conducted by a well-trained and knowledgeable Research Assistant. Following the presentation, participants will be invited to take and read brochures provided on sexual assault, and to ask questions about the content of the presentation and brochures. At 6-months, participants will be scheduled to receive A-EAAA.

06

What researchers measure

Primary outcomes

  1. Completed Rape

    The Sexual Experiences Survey Short Form Victimization (SES-SFV) will be used to measure the primary sexual assault outcomes. Completed rape will have occurred when a participant indicates she has had at least one experience of threatened, forced, or drugged completed (not attempted) sexual activity (oral, anal, or vaginal intercourse - answered 'once' or more to any of 9 questions (2c, 2d, 2e, 3c, 3d, 3e, 4c, 4d, or 4e) in the period between the baseline measurement and the 6-month survey measurement.

    Time frame: Six months after randomization

Secondary outcomes

  1. Attempted Rape

    The SES-SFV will also be used to measure secondary sexual assault outcomes: Attempted rape will have occurred when a participant indicates she has had at least one experience of threatened, forced, or drugged attempted (not completed) sexual activity (oral, anal, or vaginal intercourse - answered 'once' or more to any of 9 questions (5c, 5d, 5e, 6c, 6d, 6e, 7c, 7d, or 7e) in the period between the baseline and the 6-month survey.

    Time frame: Six months after randomization

Other outcomes

  1. Other Forms of Sexual Assault

    The SES-SFV will also be used to measure tertiary sexual assault outcomes: 1. Non-penetrative forced sexual contact will have occurred when a participant indicates she has had at least one such experience of non-penetrative sexual contact by any perpetrator strategy - answered 'once' or more to any of 5 questions (1a, 1b, 1c, 1d, 1e). 2. Completed sexual coercion will have occurred when a participant indicates she has had at least one experience of coerced (not forced) completed sexual activity (oral, anal, or vaginal intercourse - answered 'once' or more to any of 6 questions (2a, 2b, 3a, 3b, 4a, 4b). 3. Attempted sexual coercion will have occurred when a participant indicates she has had at least one experience of coerced (not forced) attempted (not completed) sexual activity (oral, anal, or vaginal intercourse - answered 'once' or more to any of 6 questions (5a, 5b, 6a, 6b, 7a, 7b).

    Time frame: Six months after randomization

  2. Self-Defense Self-Efficacy

    Measured with a questionnaire adapted by Senn et al. (2011) from Marx, Calhoun, Wilson, \& Meyerson (2001) will be used to assess changes from baseline in girls' confidence that they could defend themselves if confronted with a sexual assault situation.

    Time frame: 1-week post-intervention, six months after randomization

  3. Perception of Personal Risk

    A single item adapted from Gray, Lesser, \& Brounds (1990) will be used to measure girls' and young women's perception of their personal risk of sexual assault by male acquaintances.

    Time frame: 1-week post-intervention, six months after randomization

  4. Detection of Risk Cues

    Scenario measures will be used to assess participants' ability to detect risk in hypothetical acquaintance scenarios. At 1-week post-intervention (measure adapted from Testa et al. (2006)), at 6- -months (acquaintance scenario adapted from Messman-Moore \& Brown (2006)). Each measure can only be used once.

    Time frame: 1-week post intervention, 6-months

  5. Knowledge/Willingness to use Effective Self-Defense Strategies

    Direct Resistance subscale of Testa et al. (2006)'s measure used at 1-week post intervention. A survey adapted from Senn, Gee, \& Thake (2011) will be used to measure changes from baseline in participants' knowledge of the most effective self-defense strategies.

    Time frame: 1-week post-intervention, six months after randomization

  6. Rape Beliefs

    The Updated Illinois Rape Myth Acceptance scale (Payne et al., 1999; McMahon \& Farmer, 2011), the Perceived Causes of Rape scale (Cowan \& Campbell, 1995; Cowan \& Quinton, 1997), and the Attitudes Toward Male Sexual Violence scale (Prince et al., 1999) will be used to measure girls' beliefs about rape.

    Time frame: 1-week post-intervention, six months after randomization

  7. Experience of Embodiment

    Girls' sense of embodiment (i.e., the extent to which they feel in tune and comfortable with their bodies), measured via Piran \& Teall (2012)'s questionnaire.

    Time frame: 1-week post-intervention, six months after randomization

  8. Self-Blame Following Sexual Assault

    Behavioral self-blame subscale from Frazier et al. (2005) will be used to assess the extent to which girls who are sexually assaulted in the follow-up timeframe of the trial blame themselves for the incident(s).

    Time frame: six months after randomization

07

Study locations

1 site
  • University of Windsor
    Windsor, Ontario N9B3P4, Canada
08

References and documents

Publications

  • Senn CY, Eliasziw M, Barata PC, Thurston WE, Newby-Clark IR, Radtke HL, Hobden KL. Efficacy of a sexual assault resistance program for university women. N Engl J Med. 2015 Jun 11;372(24):2326-35. doi: 10.1056/NEJMsa1411131. PubMed 26061837 ↗
  • Senn CY, Eliasziw M, Hobden KL, Newby-Clark IR, Barata PC, Radtke HL, Thurston WE. Secondary and 2-Year Outcomes of a Sexual Assault Resistance Program for University Women. Psychol Women Q. 2017 Jun;41(2):147-162. doi: 10.1177/0361684317690119. Epub 2017 Mar 2. PubMed 29503496 ↗

Individual participant data

Plan to share: Yes — Qualified researchers will be allowed to access de-identified survey responses upon request to the PIs.

Supporting information: Study protocol, Statistical analysis plan

Time frame: from first publication (estimated 2026) for 5 years.

Access criteria: Request submitted to one of the PIs from qualified university researcher.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2023 to primary completion in Jun 2025, 27 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2023
First posted
Feb 22, 2023
StartActual
Mar 18, 2023
Primary completionActual
Jun 23, 2025
CompletionActual
Feb 3, 2026
Last update
Apr 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05738837
Lead sponsor
University of Windsor
Collaborators
Public Health Agency of Canada (PHAC)
Responsible party
Dr. Charlene Y. Senn (Distinguished University Professor, University of Windsor) — Principal investigator
First posted
Feb 22, 2023
Start date
Mar 18, 2023
Primary completion
Jun 23, 2025
Completion
Feb 3, 2026
Last update
Apr 14, 2026

Study contacts

Charlene Y Senn, PhD
principal investigator · University of Windsor
Sara E Crann, PhD
principal investigator · University of Windsor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion